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Background: Numerous cancers have been linked to microorganisms. Given that colorectal cancer is a leading
cause of cancer deaths and the colon is continuously exposed to a high diversity of microbes, the relationship
between gut mucosal microbiome and colorectal cancer needs to be explored. Metagenomic studies have shown
an association between Fusobacterium species and colorectal carcinoma. Here, we have extended these studies with
deeper sequencing of a much larger number (n = 130) of colorectal carcinoma and matched normal control tissues.
We analyzed these data using co-occurrence networks in order to identify microbe-microbe and host-microbe
associations specific to tumors.
Results: We confirmed tumor over-representation of Fusobacterium species and observed significant co-occurrence
within individual tumors of Fusobacterium, Leptotrichia and Campylobacter species. This polymicrobial signature was
associated with over-expression of numerous host genes, including the gene encoding the pro-inflammatory
chemokine Interleukin-8. The tumor-associated bacteria we have identified are all Gram-negative anaerobes,
recognized previously as constituents of the oral microbiome, which are capable of causing infection. We isolated a
novel strain of Campylobacter showae from a colorectal tumor specimen. This strain is substantially diverged from a
previously sequenced oral Campylobacter showae isolate, carries potential virulence genes, and aggregates with a
previously isolated tumor strain of Fusobacterium nucleatum.
Conclusions: A polymicrobial signature of Gram-negative anaerobic bacteria is associated with colorectal
carcinoma tissue.
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A substantial portion of the cancer burden worldwide is
attributable to microbial pathogens [1]. Certain tumor vi-
ruses, such as human papilloma virus, have the capability
of initiating tumorigenesis and are well established as
etiological agents. Although it is generally the case that
only a minority of infected individuals progress to cancer,
in principle, an overall reduction in the incidence of can-
cer can be achieved by reducing the incidence of infec-
tion. Likewise, a link between H. pylori infection and* Correspondence: rholt@bcgsc.ca
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reproduction in any medium, provided the orgastric carcinoma has been well established by more than
two decades of intensive research and, although the pre-
cise mechanism of tumor induction remains unknown, it
is possible to reduce the risk of gastric cancer by diagno-
sis and treatment of H. pylori-induced gastritis. Hence,
there are strong precedents for targeting oncogenic in-
fectious agents for the purpose of cancer control, and
motivation to explore the possibility of infectious agent
involvement in other cancers. Even in the absence of any
etiological role, a microbe or microbial signature with
tumor specificity has potential utility for diagnosis and
risk assessment.
Metagenomic analysis, whereby the presence of a
microbe in a sample is inferred from the presence of
its sequence signature, has become a sensitive method
for identifying novel tumor-associated microbes in a
culture-independent manner [2,3]. Previously, we usedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cinoma and identified substantial over-representation
of sequences mapping to Fusobacterium nucleatum
(F. nucleatum) in colorectal carcinoma (CRC) tissue
compared to adjacent non-tumor gut mucosal control
tissue from the same subjects [4]. This observation
was verified in additional CRC subjects using a quantitative
PCR assay, which targeted a F. nucleatum genome locus.
We observed significant tumor over-abundance in the
cohort as a whole, and extreme over-abundance in
approximately 25% of subjects. An independent study
of CRC, published at the same time as ours by another
team of investigators, used a nearly identical study design
and obtained nearly identical results, with a broad, signifi-
cant tumor over-representation of Fusobacterium spp. and
extreme tumor over-representation in a subset of sub-
jects [5]. Together, these reports [4,5] show an associ-
ation between Fusobacterium spp. and CRC, and highlight
the possibility of a CRC subtype where Fusobacterium spp.
may be particularly pertinent. An association between
Fusobacterium spp. abundance and metastasis was also
observed in the above studies [4,5], and a new study has
found an association between Fusobacterium spp. and
colorectal adenomas [6].
F. nucleatum is a known invasive [7] and pro-
inflammatory agent [8,9] that can cause acute and chronic
oral [10] and gastrointestinal infections [11]. We have iso-
lated Fusobacterium spp. from CRC tissue and from intes-
tinal biopsy samples taken both from healthy individuals
and Crohn’s disease patients [12,13]. The reason why
Fusobacterium spp. may in some circumstances be patho-
genic and at other times apparently benign commensal or-
ganisms is not understood. These organisms are highly
adherent [14] and will attach to host epithelial cells and
certain other bacterial species, but generally not to other
fusobacteria. Thus, in some circumstances, the pathogen-
icity of Fusobacterium spp. is thought to be related to their
ability to act as a vector, whereby they facilitate host tissue
infection by co-adherent bacteria [15].
Our initial metatranscriptomic analysis of CRC (n = 11)
had limited power to detect rarer microbes repre-
sented differentially in tumor and matched normal
control tissue, or to place the observed differential repre-
sentation in the context of the larger diversity of the muco-
sal microbiome. Here, we report a metagenomic analysis of
a much larger independent cohort of CRC patients
(n = 65). We confirm significant tumor over-representation
of Fusobacterium spp. sequences and we also observe over-
representation in tumor of sequences from additional,
less abundant bacteria, including members of the genera
Campylobacter, Leptotrichia and Selenomonas. There is
significant co-occurrence of these genera with Fuso-
bacterium and together they define a metagenomic signa-
ture of CRC.Methods
Clinical specimens
For all cases, surgical samples were obtained with in-
formed consent by the BC Cancer Agency Tumor Tissue
Repository (BCCA-TTR) [16] which operates as a dedi-
cated biobank with approval from the University of
British Columbia-British Columbia Cancer Agency Re-
search Ethics Board (BCCA REB). The BCCA-TTR plat-
form are governed by Standard Operating Procedures
(SOPs) that meet or exceed the recommendations of inter-
national best practice guidelines for repositories (NCI
Office of Biorepositories and Biospecimen Research. NCI
Best Practices for Biospecimen Resources, 2007). Speci-
mens are handled with very close attention to maintaining
integrity and isolation. Overall average collection time
(time from removal from surgical field to cryopreservation
in liquid nitrogen) for all CRC cases in the BCCA-TTR is
31 min. For this study biospecimens were held briefly
at −20°C during frozen sectioning, using 100% ethanol to
clean the blade between all samples. For each of the 65
subjects in our study, one tumor section and one matched
control specimen were analyzed, totaling 130 samples.
Metatranscriptomic analysis
Library construction and Illumina sequencing were
performed as previously described [2,4]. Briefly, frozen
tissue was homogenized in 600 μL RLT buffer (Qiagen)
and passed five times through a syringe fitted with a
20 G needle. RNA was purified using the RNeasy Plus
Mini Kit (Qiagen) following the manufacturer's instruc-
tions. Genomic DNA contamination was reduced using
an on-column DNase I treatment according to the kit
protocol. RNA quality and concentration was assessed
using Agilent Bioanalyzer 2000 RNA Nanochips. Riboso-
mal RNAs were depleted from 1 mg of total RNA using
the manufacturer’s protocol for the RiboMinus Eukaryote
Kit for RNA-Seq (Invitrogen). Depletion was assessed
using Agilent Bioanalyzer 2000 RNA Nanochips. Samples
were found to have approximately 30% residual riboso-
mal RNA content (Additional file 1: Table S1) and were
processed as described previously [17,18] for the con-
struction of Illumina libraries, with the following modifi-
cations: each paired-end library was PCR amplified for
15 cycles using the standard Illumina PE1 PCR primer
plus a modified PE2 primer including a unique six base
insertion as an index sequence. Libraries prepared using
indexed primers were then combined in two pools of 60
and 70 samples, respectively, with each pool containing
both tumor and control libraries. Libraries were gel puri-
fied to remove residual adapter dimers and then sequenced
on the Illumina HiSeqtm 2000 platform. Four paired-end
100 nt sequence lanes were run per multiplexed library for
a total of 8 lanes, yielding 564.4 million raw read pairs.
Reads were aligned on a per-lane basis against a sequence
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BWA [20] (v0.5.9 -o 1000). Aligned reads, reads having
stretches of homopolymeric DNA bases and poor quality
bases were discarded. The remaining paired reads (334.5
million or 59.3% of total sequence) were aligned using
BWA with the same parameters against 155,209 transcript
sequences [19], after which unmapped paired reads
subtracted and re-aligned against the NCBI reference
human genome sequence [21]. A total of 390 million
read pairs (69.1%) aligned to human sequence databases
and were subtracted (Additional file 1: Table S1). The
remaining unmapped read pairs were aligned against a
sequence database of bacterial and viral RefSeq genome
sequences from Genbank [22] and reference bacterial
genome sequence from HMP [23] using Novoalign
(http://www.novocraft.com; v2.7.9 -o SAM -r A -R 0),
tracking unique alignments within genera and species.
We chose to run Novoalign rather than BWA for the
last step of the microbe profiling pipeline because it is a
more permissive aligner that reports all high scoring
alignments for a given read pair, which facilitates the
unambiguous assignments of read pairs. Paired sequence
reads that mapped both as top hits and as unique hits
(i.e., to a single species or genus) were tallied and orga-
nized by organism at the genus or species level using
the binomial nomenclature (Additional file 2: Table S2
and Additional file 3: Table S3). All pairs that satisfied
these conditions and aligned within Novoalign’s allow-
able mismatches (≤16 per pair of reads) were tracked.
Thus, all 100 nt read pairs aligning within 92% sequence
identity or better were tallied. A total of 4.7 million read
pairs (0.8% of total raw sequenced pairs) aligned to mi-
crobial genome sequences using the approach described
here. Read pair counts were then normalized to account
for the variation in the amount of raw sequence data
generated per sample. Briefly, the average number of
raw reads for all samples was determined. The number
of raw reads from each sample, as a proportion of the
average read count, was also determined and used as a
correction factor. For each sample, the number of reads
mapping to each microbe was divided by the correction
factor specific to that sample to obtain the normalized
count. Samples were further arranged by biospecimen
type (i.e., normal vs. tumor) and the significance of dif-
ferentially abundant microbes, as inferred from differen-
tially abundant and uniquely mapped read pairs, using
the R function of Metastats [24].
Microbe co-occurrence was investigated by selecting
any two genera and calculating a Pearson correlation R
between their sequence pair count. Read counts for the
two genera were then re-assigned to sample identifiers
randomly, 1,000 times, and the Pearson correlation re-
assessed and the correlation R between two genera was
assigned a bootstrap P value equal to the proportion ofrandomizations that resulted in an R value equal or
greater to the initial R value calculated from the non-
randomized data.
Correlations among genera were plotted as a net-
work using Cytoscape v2.8.2 [25], with the color inten-
sity of each edge corresponding to the strength of the
Pearson correlation, lighter to darker matching Pearson
R = 0.5046 to R = 0.9909.
Principal component analysis was performed using the
ade4 package in R [26] to determine whether tumor and
normal control tissue could be distinguished, globally, by
microbiome content.
Host gene expression profiling
Read pairs aligning to Ensembl human transcripts
that had been segregated during the filtering steps
described above were analyzed further. The number
of read pairs matching each Ensembl transcript were
counted and then, because Ensembl transcripts are
partially redundant due to alternative splicing, read-
pair counts from transcripts were consolidated by
Ensembl gene IDs, to provide a read-pair count for
each gene. After normalizing, as above, for raw se-
quence depth, we calculated the Pearson correlation
R between ratios (tumor/normal) of read-pairs map-
ping to each distinct human gene to ratios of read-
pairs mapping to each distinct bacterial genus.
To test significance, read-pair ratios were randomly
re-assigned to sample identifiers 1,000 times and the
Pearson correlations re-assessed. Each correlation was
assigned a bootstrap P value equal to the proportion of
randomizations that resulted in an R value equal or
greater to the initial R value calculated from the non-
randomized data.
HLA prediction
HLA class I alleles were predicted directly from the
RNA-Seq data as described [27]. Briefly, HLA sequence
contigs were derived from the RNA-Seq data by targeted
de novo assembly using TASR [28] and assessed by re-
ciprocal BLASTN [29] against reference HLA allelic se-
quences available in the public domain (IMGT/HLA)
[30]. Top scoring allele predictions for all 65 subjects are
provided in Additional file 4: Table S4. For the 14 sub-
jects with the predicted HLA class I extended haplotype
A*01 B*08 C*07 [31], the computational predictions
were verified by PCR based Sanger re-sequencing as pre-
viously described [32].
Campylobacter showae CC57C sequencing, assembly and
annotation
A strain of Campylobacter showae (C. showae), which
we named CC57C, was cultured from a tumor surgical
section using previously described methods [4]. CC57C
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formate (0.2% w/v) and sodium fumarate (0.3%w/v) [33],
HMW genomic DNA was extracted and purified, and
used to construct an Illumina whole genome shotgun se-
quencing library using standard methods. The library
was sequenced on the Illumina MiSeq platform which
generated 1.8 million paired 150 nt reads after quality fil-
tering, providing 245.4 mean fold coverage of the ap-
proximately 2.2 Mbp genome. Read pairs were assembled
with the onboard Velvet short read assembler [34], pro-
ducing 300 contigs with an N50 length of 16.8 kbp. The
contigs were aligned onto the closest known reference
genome, C. showae RM3277 (NCBI Reference Sequence:
NZ_ACVQ00000000.1) using cross_match (parameters -
minmatch 29 -minscore 59 -masklevel 101, http://www.
phrap.org) and displayed using XMatchView (http://
www.bcgsc.ca/platform/bioinfo/software/xmatchview).
CC57C genome annotation was inferred from BLASTX
alignments between CC57C contigs and the protein data-
base Genbank-nr [22].
Assessment of F. nucleatum CC53 / C. showae CC57C
co-aggregation
F. nucleatum tumor isolate strain CC53 identified in a
previous study by our group [4] was cultured in tryptic
soy broth supplemented with menadione (1 μg/mL) and
hemin (5 μg/mL) (TSBsupp), and C. showae tumor iso-
late strain CC57C was cultured in TSBsupp with further
supplementation of sodium formate (0.2% w/v) and so-
dium fumarate (0.3% w/v), under strict anaerobic condi-
tions for 2 days at 37°C.
To assess whether CC53 and CC57C were able to
co-aggregate, cells were harvested by centrifugation at
10,000 rpm for 10 minutes at 4°C, washed in co-
aggregation buffer (0.01 M Tris–HCl adjusted to pH
8.0, 0.001 M MgCl2, 0.15 M NaCl and 2% NaN3) ref.
three times and finally re-suspended in co-aggregation
buffer to a turbidity of between McFarland standard 2.0
and 3.0 (~108 CFU/mL). Aliquots (0.5 mL) of each
strain were mixed and vortexed for 10 s followed by in-
cubation at 37°C for 30 min with agitation at 110 rpm.
After incubation the tubes were removed and allowed
to sit undisturbed for 3 min to allow aggregates to set-
tle. Aggregate samples were immobilized on agarose-
coated slides and observed by phase microscopy.
Preparation of cells for electron microscopy
CC57C cells were cultured in TSBsupp with further sup-
plementation of sodium formate (0.2% w/v) and sodium
fumarate (0.3% w/v) as above for two days as above.
Cells were harvested by centrifugation, washed twice
with distilled water, floated to Formvar-coated grids, and
stained with 0.5% uranyl acetate prior to viewing with a
Philips CM10 electron microscope.Results
Metatranscriptomic analysis of CRC and matched control
tissue reveals differentially abundant microbes
Total RNA was isolated from frozen surgical sections of
CRC and matched unaffected control tissue from 65 sub-
jects. Following ribosomal RNA depletion, multiplexed
RNA-Seq libraries were constructed as previously de-
scribed [2,4], and eight paired-end lanes of sequence
were obtained using the Illumina HiSeqtm 2000 platform.
After quality filtering of the raw sequence data and re-
moval of human sequences, microbial sequence diversity
was assessed by counting read pairs having unique align-
ments to genomes of specific bacterial genera, using an
in-house database populated with all microbial genome
sequences available from GenBank [22] and the Human
Microbiome Project [35]. Aligned read pairs were nor-
malized to correct for differential yield of raw sequence
data from different samples. Considering the filtered and
uniquely mapped sequences of microbial origin (Table 1
and Additional file 1: Table S1 and Additional file 2:
Table S2), 57 distinct genera accounted for 99% of the
mapped read pairs, and this set of frequent bacteria was
analyzed further. Relative microbial abundance in the
tumor and normal groups was inferred from the differen-
tial abundance of uniquely mapped reads by running
Metastats [24].
Relative abundance within the set of 57 frequent bac-
terial genera varied by approximately four orders of mag-
nitude (Figure 1A; Additional file 5: Table S5). Ralstonia
and Bacteroides, both of which are known constituents
of the normal fecal microbiota, were of highest abun-
dance in both tumor and control samples. Genera we
found to be nominally over-represented in control sam-
ples relative to tumors (Ruminococcus, Parabacteroides,
Pseudoflavonifractor, Ruminococcaceae and Holdemania)
are also well-recognized members of the fecal microbiota
[36]. Fusobacterium was the most abundant genus sig-
nificantly over-represented in tumor samples, as previ-
ously reported [4,5]. Interestingly, however, analysis of
this comprehensive metagenomic data set revealed add-
itional genera, namely Campylobacter and Leptotrichia,
which are significantly over-represented in tumor
samples after accounting for multiple testing. Tumor
over-representation of Selenomonas is only nominally
significant (Additional file 5: Table S5). These additional
genera have comparatively low representation in the tumor
microbiome, but high tumor specificity. Principal compo-
nent analysis did not distinguish tumor from normal con-
trol tissue on the basis of global microbiome content
(Additional file 6: Figure S1).
To explore species-level representation of the tumor-
associated genera, we counted read pairs mapping
uniquely to genome accessions of member species
(Figure 1B). The species showing greatest number of
Table 1 Sequence statistics
Sample type Control Tumor
Number of patient
samples
65 65
Read pairs Minimum Maximum Mean ± SD Proportion of raw
read pairs (%)
Minimum Maximum Mean ± SD Proportion of raw
read pairs (%)
Raw sequenced 2,393,763 5,991,413 3,854,055 ±
731,259
100.0 1,467,161 10,121,411 4,371,501 ±
1,435,367
100.0
Quality filtered and host
subtracted
747,357 2,404,589 1,259,480 ±
288,807
32.7 507,402 3,426,796 1,403,283 ±
475,582
32.0
Mapping unambiguously to
microbial genomes
646 792,618 44,625 ±
103,949
1.2 445 219,314 27,191 ±
39,676
0.6
Distinct microbial genera
observed
372 411
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F. nucleatum, C. showae, L. hofstadii and S. sputigena. For
each of these species, there was an over-representation of
mapped read pairs that were of tumor origin. Within each
genus, additional species showed unique read pair matches,
but the matches were generally fewer and showed less
tumor specificity. We have restricted our analysis to se-
quence pairs that map as best hits, uniquely to the refer-
ence genomes shown because this is the most tractable
approach, however, this approach cannot yield completeFigure 1 Microbial abundance in CRC and unaffected control gut mucos
from unique metatranscriptomics read pair mapping. Genera (n = 57) comprisi
presented are the mean percent abundance ± SE, on a log10 scale. Genera are
tissue. The names of genera nominally over-represented in tumor (P <0.05) are
(P <0.05) are green. Genera indicated with an asterisk are significantly over-repr
(q <0.05); (B) Species distribution of uniquely mapped Fusobacterium, Leptotrichgenome information for tumor microbes. Therefore, we
cannot state with certainty that these are the precise spe-
cies present. It is possible that regions of individual ge-
nomes we have not sampled would, if available, match best
to reference genomes from different species. Likewise, the
sequences we have obtained from tumor microbes might
best match species that are not yet represented in micro-
bial genome databases. It is expected that precision in mi-
crobial identification at the finer taxonomic levels will
improve as microbial genome resources improve.a tissue measured by RNA-Seq. (A) Phylogenetic abundance inferred
ng, collectively, 99% of the microbial sequence data are shown. Values
ordered top to bottom by decreasing read pair abundance in control
red, and the names of genera nominally under-represented in tumor
esented in tumor samples after multiple hypothesis testing correction
ia, Campylobacter and Selenomonas normalized sequence pairs.
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patterns of co-occurrence in CRC
Next, we asked if the bacteria showing mean differential
abundance between the tumor and control samples
showed a tendency toward co-occurrence. That is, we
were interested to determine if these bacteria tended to
be differentially abundant in the same samples. Using
read count data, we calculated correlation coefficients for
all possible pairwise combinations of genera and assessed
the significance of these correlations by iterative retesting
after randomization of the association between genus
abundance and sample identifier. The resulting co-
occurrence network is illustrated in Figure 2A and shows
very distinct clustering of the tumor-enriched genera, in-
dicating a tendency of these genera to co-occur within
the same specific samples. Conversely, genera initially
found to be nominally over-represented in control tissue
did not specifically cluster, but rather grouped with the
majority of the other non-differentially abundant genera
that represent the commensal microbiota.
Correlation between host factors and microbial
abundance
Our RNA-Seq data provided only light coverage of the
human transcriptome, but nonetheless this allowed the
opportunity to explore patterns of host gene expression
in relation to differentially abundant bacteria. We aligned
the RNA-Seq data to Ensembl [19] transcripts (consoli-
dated by Ensembl gene ID), and identified a total of
12,963 distinct expressed human genes and these varied
widely in expression level (Additional file 7: Figure S2).
Across all 130 tissue samples 5,384 genes were matched
by an average of ten read pairs or more. Read counts
for each of the nine bacterial genera showing at least
nominally significant mean differential abundance be-
tween tumor and control samples (Figure 1A) were cor-
related with read counts for each of the 12,963 human
genes. As above, significance was assessed by iterative
randomization and retesting of the association between
sample identifier and gene expression level. As illus-
trated in the network diagram presented in Figure 2B
and Additional file 8: Table S6, genera over-represented
in tumor tissue were associated with eight differentially
expressed host genes, including known oncogenes and
immune response genes. Genera under-represented
in tumor tissue were associated with 28 differentially
expressed host genes, including numerous housekeeping
genes but no genes that have obvious, well established im-
plications in cancer, infection, or immunity.
To further explore host immunity we predicted the
HLA class I alleles for all subjects using a computational
approach [27] that involved targeted assembly of RNA-
Seq reads matching HLA-A, -B and -C genes [28]
followed by identification of the most likely allele calls asbest reciprocal BLASTN [29] matches to reference allele
sequences from the IMGT/HLA database [30] (Additional
file 4: Table S4). We did not observe an association be-
tween any individual HLA allele and genus with differential
tumor abundance. Interestingly, however, 14 subjects were
predicted to carry the extended ancestral haplotype A*01
B*08 C*07 [31] and showed a tendency toward tumor en-
richment of Fusobacterium (tumor ratio of 126 ± 344 in
A*01 B*08 C*07 subjects versus 30 ± 91 in other subjects),
although this difference was not statistically significant
(Student’s t-test).
Characterization of a novel C. showae tumor isolate
The tissue specimens interrogated in the present study
were biobank specimens and were not initially collected or
stored with the intention of facilitating the subsequent
culture of anaerobic bacteria. Nonetheless, given the ob-
servation from our metatranscriptomic analysis of over-
representation of certain anaerobes, culture was attempted,
and we were able to obtain a single Campylobacter spp.
isolate, CC57C. Phenotypically, on agar plates, colonies of
C. showae CC57C appear circular, small, extremely flat and
opaque/translucent. By electron microscopy (Additional
file 9: Figure S3) cells generally possess a single polar flagel-
lum. This is in contrast to the description of the type strain
for C. showae, ATCC 51146T, which has 2 to 4 unipolar
flagella per cell, but similar to the phenotype for C. rectus
and C. concisus, both of which are reported as having 1
polar flagella per cell [33].
The genome of the C. showae CC57C isolate was se-
quenced using the Illumina MiSeqtm platform and the
resulting genome assembly showed highest DNA sequence
homology with that of the HMP reference C. showae
RM3277. However, whole-genome alignments show that
these two genomes (C. showae CC57C and C. showae
RM3277) are actually fairly substantially diverged, with
only 92.5% average nucleotide sequence identity. Further,
15% of the C. showae RM3277 genome is not represented
by contigs of the C. showae CC57C assembly and, although
there is inherent difficulty in comparing draft genome
assemblies, the two genomes appear to show significant
local rearrangement (Figure 3A). Interestingly, there are
C. showae CC57C sequence contigs that harbor predicted
genes that have no equivalent in C. showae RM3277. One
such contig captures VirB4/D10 operon homologs, compo-
nents of a Type IV Secretion System (T4SS) specific to an-
aerobes, which was first described in the plant pathogen
Agrobacterium tumefaciens [37]. T4SS are used by patho-
genic anaerobic bacteria to translocate DNA and protein
substrates across their membranes and into recipient cells
[38]. The configuration of the Vir operon of C. showae
CC57C (Figure 3B) shows strong similarity to that of
C. rectus RM3267 and also similarity to that present within
the cag pathogenicity island of H. pylori. In H. pylori this
Figure 2 Bacterial co-occurrence and correlation with host gene expression. (A) The co-occurrence of microbes was inferred by pairwise
correlation of sequence counts for all genera in Figure 1. Significance was determined by 1,000 iterations of random re-assignment of sequence
read pairs to subjects, with re-calculation of Pearson correlation coefficients. Interactions of significantly differentially abundant genera are
illustrated here in a network diagram, constructed using Cytoscape [25]. Pearson R values ranged from a low of 0.51 (Holdemania-Haemophilus) to
a high of 0.97 (Fusobacterium-Selenomonas). Each prefix within a node of the network indicates a bacterial genus: Sp: Sphingobium; Sh: Sphingopyxis;
Si: Sphingomonas; La: Lactobacillus; Bi: Bifidobacterium; No: Novosphingobium; Se: Selenomonas; Fu: Fusobacterium; Ro: Roseburia; Eg: Eggerthella;
Bl: Blautia; Cl: Clostridium; Ve: Veillonella; Ha: Haemophilus; Co: Coprococcus; Ps: Pseudoflavonifractor; Do: Dorea; Ru: Ruminococcus; Bu: Butyrivibrio;
Cs: Clostridiales; Ca: Campylobacter; Le: Leptotrichia; Pa: Parabacteroides; Ba: Bacteroides; Rm: Ruminococcaceae; Er: Erysipelotrichaceae; En: Enterococcus;
Br: Burkholderia; Ph: Phascolarctobacterium; Lw: Lawsonia; Al: Alistipes; Su: Subdoligranulum; Od: Odoribacter; Po: Porphyromonas; Bk: Burkholderiales;
Go: Gordonibacter; Gr: Granulicatella; Di: Dialister; Fa: Faecalibacterium; Eu: Eubacterium; De: Desulfovibrio; Pr: Parvimonas; Pe: Peptostreptococcus;
An: Anaerotruncus; Ci: Collinsella; Or: Oribacterium; Ho: Holdemania; Es: Escherichia; Pv: Prevotella; Me: Methylobacterium; Bd: Bradyrhizobium; Ra: Ralstonia.
(B) The host factor and microbe interaction was inferred by comparing the relative read pair abundance in the tumor vs. the control samples for each
patient. The red and green nodes correspond to microbes with at least nominally significant differential abundance between tumor and control tissues.
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host stomach epithelium cells [39,40] and, although we
do not observe a cagA equivalent in C. showae CC57C, the
function of this secretion system in C. showae CC57Cdeserves further scrutiny, due to its potential association
with virulence. The presence of Relaxase and Nucleotidyl
transferase genes in the C. showae CC57C operon sug-
gests a nucleic acid transport function. Annotation of the
Figure 3 Genome sequence analyses of C. showae tumor strain CC57C. (A) Sequence alignments between the assemblies of the CRC
tumor-associated C. showae CC57C genome and that of its closest known relative reference, C. showae RM3277. Velvet contigs from the CC57C strain
were aligned to the HMP reference strain (NCBI Reference Sequence: NZ_ACVQ00000000.1) using cross_match (http://www.phrap.org), ordered and
oriented based on the sequence alignments. The black and grey rectangles represent each genome sequences and indicate the absence and presence
of alignments, in that order. Co-linear and inverted sequence alignment blocks are shown in blue and pink, respectively. In average, the CC57C genome
assembly is 92.5% identical to that of the RM3277 strain, with 85.4% sequence coverage (represented by the dark blue and lack of bars in the histogram
above the alignment, respectively). (B) Gene organization of the type IV secretion system (T4SS) operon in A. tumefaciens (plasmid pTiAB2/73 vir region
AF329849), H. pylori strain 26695 (NC_000915.1), C. rectus (NZ_ACFU0100008) and C. showae CC57C (AOTD01000166). Components of the T4SS found in
the CC57C strain are color-coded in other organisms and include VirB4 (red), VirB8 (blue), VirB9 (green), VirB10 (orange), VirB11 (yellow) and VirD4 (purple).
Other annotated genes within the CC57C operon and with homologs in C. rectus are shown using a dark grey scale. Annotated genes in C. rectus, H.
pylori and A. tumefaciens are shown in light grey. Hypothetical protein coding genes are depicted in white. CC57C contig AOTD01000166 with the T4SS
shown in (B) does not have any similarity to the C. showae RM3277 strain and thus is not represented in the alignment shown in (A).
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interest regarding potential pathogenicity, including genes
encoding various adhesion, motility, chemotaxis and se-
cretion functions (Additional file 10: Table S7). Numerous
antibiotic resistance genes are also observed, including
those coding for beta-lactamase and the multidrug resist-
ance protein MEXB, suggesting that antibiotic treatment
for this particular strain of C. showae may be problem-
atic. Of note, our BLASTX-based annotation of the draft
C. showae CC57C genome is very conservative, and weexpect that many additional genes will be revealed upon
further curation.
The availability of F. nucleatum CC53 from our previ-
ously published study [4] and the availability of C. showae
CC57C from the present study allowed us to test whether
these strains interact (aggregate) with each other in vitro
using a simple aggregation test. Using phase microscopy
we found that these two strains aggregated readily with
each other, indicating the presence of compatible adhesins/
receptors on the bacterial cell surfaces (Figure 4).
Figure 4 F. nucleatum and C. showae co-aggregation.
Phase-contrast microscopy images of (A) F. nucleatum CC53 alone,
(B) C. showae CC57C alone and (C) a mixture of CC53 and CC57C,
following incubation in co-aggregation buffer (see methods). The long,
thin cells of CC53 readily self-aggregate when incubated in
aggregation buffer alone (panel A), but also show aggregative ability
with the much smaller CC57C coccobacilli (panel C). Images were
taken using a Leica DM750 microscope fitted with a 100× oil objective,
using the Leica Application Suite LAS EZ Version 1.7.0 software.
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Using deep metatranscriptomic sequencing and analysis
we have determined that in addition to Fusobacterium,
there are Leptotrichia and Campylobacter spp. co-enriched
in CRC tissue. These bacteria are all Gram-negative
anaerobes that are known commensal members of the
oral microbiome, typically the subgingival plaque [33,41],
and they have pathogenic potential. Fusobacterium
and Leptotrichia are relatively closely-related organ-
isms. The order Fusobacteriales contains three families,
of which Leptotrichiaceae and Fusobacteriaceae are two.
Leptotrichia spp. have been isolated from periodontal
lesions and from a diversity of other cardiovascular,genitourinary and gastrointestinal abscesses and from
systemic infections, and have been suggested to be
potential emerging pathogens [42]. In our study the
Leptotrichia spp. showing the largest number of unique
read-pair alignments from our data is L. hofstadii,
followed closely by L. buccalis. Previous case studies
have reported L. buccalis bacteremia in patients with
cancer [42,43], however, the cancers in question were
mainly lymphomas and leukemias, and thus bacteremia
was likely related to the immuno-compromised state of
the patients, rather than to the malignancy directly.
The Campylobacter spp. showing the largest number of
unique read-pair alignments from our data set was
C. showae. This is a relatively new member of the Campylo-
bacter genus, first described in 1993 [33] after isolation
from subgingival plaque. C. showae and originally distin-
guished from other Campylobacter based on number of fla-
gella. The presence of flagella also distinguishes C. showae
from the other tumor-associated bacteria in our study,
Fusobacterium and Leptotrichia, which are non-flagellated.
Interestingly, we did not observe any unique se-
quence matches to Campylobacter jejuni, which is a
well-characterized human pathogen that is a leading cause
of acute, food-borne gastroenteritis [44]. Previous studies
have not found epidemiological evidence for a link between
C. jejuni infection and cancer, which is consistent with our
observation of the absence of C. jejuni from the CRC tumor
microbiome. Importantly, however, no data are available re-
garding the possible involvement of other Campylobacter
species in cancer. The possibility that Campylobacter,
Leptotrichia, or Fusobacterium spp. associated with CRC
may have an etiological role in carcinogenesis remains an
open and difficult question that requires further study.
The metatranscriptomic data presented here indi-
cate that in the samples we analyzed, Fusobacterium,
Leptotrichia and Campylobacter spp. tend to be found to-
gether. This is not unexpected given that all are anaerobic
microbes known to inhabit the same niche in the oral cav-
ity. In general, F. nucleatum strains are remarkable in their
abilities to co-aggregate with a wide variety of bacterial
species [45,46]. In line with this, we demonstrate here that,
in vitro, aggregation of tumor isolates C. showae CC57C
with F. nucleatum CC53 [4] is evident (Figure 4). Co-
aggregation of Streptococcus cristatus with F. nucleatum
has previously been shown to facilitate invasion of the
former into cultured host cells, and to alter the host
response to F. nucleatum invasion [47,48]. Whether co-
aggregation of F. nucleatum and C. showae is relevant to
disease etiology remains to be tested and the influence of
this co-aggregation on bacterial virulence in vitro is cur-
rently being investigated by our group.
The strong association between what are typically con-
sidered oral anaerobic bacteria and colorectal carcinoma
is intriguing. These species together may provide a set of
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tection and risk assessment. An important question is
whether these tumor bacteria are of oral origin, or if they
represent distinct colonic strains or even, possibly, distinct
tumor strains. Comparative analysis of large numbers of
tumor isolates will be needed to address this question. To-
wards this goal, we describe a novel C. showae strain,
CC57C, isolated from colorectal carcinoma tissue which
shows considerable divergence from its closest known rela-
tive, C. showae RM3277, an oral strain. CC57C carries
genes implicated previously in pathogenicity, including a
virB10/D4 type IV secretion system that is present in
CC57C but absent from RM3277.
An advantage of our approach of using RNA-Seq to in-
terrogate surgical tissue for the presence of associated mi-
crobes is that it also provided the opportunity to explore
possible links of the microbiota to host genetic factors. We
were able to predict HLA class I alleles for most subjects
by directly mining the RNA-Seq data using a new tool,
HLAminer, which avoided the extra time and cost that
would otherwise be required for conventional typing. Al-
though we do not see a significant association between
HLA class I type and the abundance of specific microbes,
we anticipate that in future this approach will be amenable
to the analysis of larger microbiome datasets that are more
appropriately powered for the detection of HLA associa-
tions. We also asked if differentially abundant bacteria were
associated with any differentially expressed host genes.
Notably, within the small set of genes associated with
tumor-enriched bacterial signatures, we observed cathepsin
Z, a tumor associated protease, and interleukin-8, an in-
flammatory cytokine and mediator of innate immunity se-
creted by activated macrophages. We expect that further
definition of the interaction between host cells and the an-
aerobic bacteria identified in this study will be an import-
ant focus of ongoing investigation.
Conclusions
A high-throughput sequence screen of Metatranscriptome
data from CRC and matched control tissues has revealed
differently abundant microbial genome sequence sig-
natures of significance in tumor samples, including
those belonging to the Fusobacterium, Campylobacter
and Leptotrichia genera. These Gram-negative anaerobes
are typically considered to be oral bacteria. However,
tumor isolates for Fusobacterium and Campylobacter are
genetically diverged from their oral counterparts and carry
potential virulence genes. Interestingly, we observe that
sequence signatures from Fusobacterium co-occur with
those from Leptotrichia and Campylobacter and that
Fusobacterium and Campylobacter strains isolated from
tumor tissue co-adhere in culture. A non-invasive
assay to detect this polymicrobial signature of CRC
may have utility in screening and risk assessment. Itremains unknown whether there is any etiological link
between microorganisms and CRC. In principle, any
such link could provide a point of intervention.
Availability of supporting data
The data sets supporting the results of this article are
available in the NCBI Sequence Read Archive repository,
http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi under ac-
cession no. SRP010181. These include human CRC RNA-
Seq as well as C. showae CC57C WGS reads. The whole
genome shotgun project for the C. showae CC57C tumor
isolate has been deposited at DDBJ/EMBL/GenBank under
the accession AOTD00000000. The version described in
this paper is the first version, AOTD01000000.
A file containing patient ID, sample ID and sequencing
library names is available at http://ftp.bcgsc.ca/supplemen-
tary/CRC2012/SRP0010181_CRC_info.txt. Other data sets
supporting the results of this article are included within
the article and its Additional files.Additional files
Additional file 1: Table S1. NGS sequence read alignment summary.
Additional file 2: Table S2. Normalized NGS sequence read pairs
aligning as best hits to a unique genus.
Additional file 3: Table S3. Normalized NGS sequence read pairs
aligning as best hits to a unique genus.
Additional file 4: Table S4. HLA allele assignments.
Additional file 5: Table S5. Differentially represented genera from top
99% microbial abundance. Sequence reads normalized for depth of
sequencing were analyzed using statistical methods in the Metastats
package [24], which were designed for comparing clinical metagenomic
samples from two treatment populations on the basis of read count data.
Rare microbes (collectively <1% of sequence data) were excluded from
analysis. Genera highlighted in RED are nominally over-represented in
tumor tissue relative to matched normal control tissue (P <0.05), and
genera highlighted in GREEN are nominally under-represented in tumor
tissue (P <0.05). Genera shown in bold indicate significantly over-
represented microbes in the tumor tissue (q <0.05).
Additional file 6: Figure S1. Microbiome profiles of normal and tumor
samples do not group separately. Principal component analysis with
sample types (normal, tumor) as instrumental variables, based on the
abundance of 57 genera (representing 99% of the microbe abundance)
in 65 normal and 65 tumor samples. Two first components were plotted
using the ade4 [26] package in R and represented 68% of the variance.
CRC patients (xy points) were clustered and center of gravity (with labels
normal and tumor centered in each ellipse) computed for each class.
Additional file 7: Figure S2. Unique read pair alignment distribution.
Paired read alignments were performed as described in methods, the
number of raw pairs aligning unambiguously was tallied for each
transcript/sample and consolidated per Ensembl gene.
Additional file 8: Table S6. Microbe and host factor correlation.
Additional file 9: Figure S3. Representative transmission electron
microscopy image of Campylobacter strain CC57C, stained with 0.5%
uranyl acetate. In most cases, only a single unipolar flagellum was seen
associated with each cell (arrows). The lack of sharply defined edges
around cells may indicate the presence of a capsule. Image taken using a
Philips CM10 electron microscope.
Additional file 10: Table S7. Gene annotation of the C. showae CC57C
genome.
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